Compare WFCF & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WFCF | ESLA |
|---|---|---|
| Founded | 1996 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.3M | 60.9M |
| IPO Year | 2006 | N/A |
| Metric | WFCF | ESLA |
|---|---|---|
| Price | $13.15 | $1.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 1.6K | ★ 45.1K |
| Earning Date | 05-07-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $20,774,416.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $45.83 | ★ N/A |
| Revenue Growth | ★ 16.69 | N/A |
| 52 Week Low | $9.69 | $0.73 |
| 52 Week High | $13.75 | $3.15 |
| Indicator | WFCF | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 60.96 | 45.62 |
| Support Level | $10.96 | $0.91 |
| Resistance Level | $13.57 | $1.35 |
| Average True Range (ATR) | 0.19 | 0.14 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 81.22 | 24.86 |
Where Food Comes From Inc is a third-party food verification company conducting both on-site and desk audits to verify that claims being made about livestock, food, other high-value specialty crops and agricultural and aquaculture products are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. It also provides a wide range of professional consulting services. It generates the majority of its revenue from Verification and certification services.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.